Showing 1 - 20 results of 56,902 for search '(( 5 wt decrease ) OR ((( 5 e decrease ) OR ( 50 ((ng decrease) OR (_ decrease)) ))))*', query time: 1.00s Refine Results
  1. 1
  2. 2
  3. 3

    eNOS phosphorylation increased intracellular ROS generation and decreased cell viability in BH4-depleted cells. by Hu Peng (396074)

    Published 2015
    “…HEK293 eNOS control, *, <i>p</i> < 0.01). 50ng/mL VEGF caused further decrease of cell viability in eNOS overexpressing HEK293 cells treated with 10mM DAHP (VEGF plus DAHP vs. …”
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

    Published 2013
    “…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H<sub>2</sub>O<sub>2</sub> (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”
  11. 11

    Lack of p23 results in decreased epidermal thickness, delayed differentiation and increased rates of proliferation and apoptosis in E18.5 skin. by Marta Madon-Simon (527400)

    Published 2017
    “…(<b>b</b>) Quantitation of epidermal thickness and (<b>c</b>) number of hair follicle per 100 μm basal membrane (BM) in <i>p23</i><sup><i>-/-</i></sup> and wild-type E18.5 skin sections; significant decrease of epidermal thickness (*** p<0.001) and hair follicle numbers (** p<0.01) in <i>p23</i><sup><i>-/-</i></sup> skin (n: WT = 4, <i>p23</i><sup><i>-/-</i></sup> = 3). …”
  12. 12
  13. 13
  14. 14
  15. 15

    SPL treatment decreases diabetes-induced decrement in protein expression of cldn-5 in glomeruli (GL) and cldn-2 and occldn in proximal tubules (PT). by Eduardo Molina-Jijón (4020464)

    Published 2017
    “…<p>SPL prevents diabetes-induced decrease of cldn-5 protein expression (A and B) in GL, and mRNA (F) and protein expression of cldn-2 (A and C), and protein expression of occldn (A and D) in PT (<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0177362#pone.0177362.s002" target="_blank">S2 Fig</a>). …”
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20